สารยับยั้งกำเนิดหลอดเลือด
เชิงอรรถและอ้างอิง

↑
"genesis", ศัพท์บัญญัติอังกฤษ-ไทย, ไทย-อังกฤษ ฉบับราชบัณฑิตยสถาน (คอมพิวเตอร์) รุ่น ๑.๑ ฉบับ ๒๕๔๕, (แพทยศาสตร์) กำเนิด, การทำให้เกิด
"genesis", ศัพท์บัญญัติอังกฤษ-ไทย, ไทย-อังกฤษ ฉบับราชบัณฑิตยสถาน (คอมพิวเตอร์) รุ่น ๑.๑ ฉบับ ๒๕๔๕, (แพทยศาสตร์) ๑. สารยับยั้ง [= static ๓] ๒. สิ่งรั้ง, สิ่งยับยั้ง; (วิทยาศาสตร์) ตัวยับยั้ง
↑  Hayden, EC (April 2009). "Cutting off cancer's supply lines". Nature. 458 (7239): 686–7. doi:10.1038/458686b. PMID 19360048.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Cancer.com [homepage on the Internet]. National Cancer Institute at the National Institutes of Health; 2011 [cited 18 March 2014]. Available from:
"Archived copy". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 8 February 2015. สืบค้นเมื่อ 2007-01-26.{{cite web}}:  CS1 maint: archived copy as title (ลิงก์)
↑  Ng, EW; Adamis, AP (June 2005). "Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration". Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie. 40 (3): 352–68. doi:10.1016/S0008-4182(05)80078-X. PMID 15947805.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2 3 4  
Folkman, J (2004). "Endogenous angiogenesis inhibitors". Apmis. 112 (7–8): 496–507. doi:10.1111/j.1600-0463.2004.apm11207-0809.x. PMID 15563312.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  
Cao, Y (April 2001). "Endogenous angiogenesis inhibitors and their therapeutic implications". The International Journal of Biochemistry & Cell Biology. 33 (4): 357–69. doi:10.1016/s1357-2725(01)00023-1. PMID 11312106.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Rini, BI (February 2007). "Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions". Clinical Cancer Research. 13 (4): 1098–106. doi:10.1158/1078-0432.CCR-06-1989. PMID 17317817.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2 3  Nyberg, P; Xie, L; Kalluri, R (May 2005). "Endogenous inhibitors of angiogenesis". Cancer Research. 65 (10): 3967–79. doi:10.1158/0008-5472.CAN-04-2427. PMID 15899784.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Marti, Hugo H, "Vascular Endothelial Growth Factor", Madame Curie Bioscience Database, Landes Bioscience, สืบค้นเมื่อ 2012-01-25
↑  Kamphaus, GD; Colorado, PC; Panka, DJ; Hopfer, H; Ramchandran, R; Torre, A; Maeshima, Y; Mier, JW; Sukhatme, VP; Kalluri, R (January 2000). "Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth". The Journal of Biological Chemistry. 275 (2): 1209–15. doi:10.1074/jbc.275.2.1209. PMID 10625665.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Lee, SJ; Nathans, D (March 1988). "Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors". The Journal of Biological Chemistry. 263 (7): 3521–7. PMID 2963825.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Gardlik, R; Behuliak, M; Palffy, R; Celec, P; Li, CJ (2011). "Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy". Gene therapy. 18 (5): 425–431.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Xu, YF; Zhu, LP; Hu, B; Fu, GF; Zhang, HY; Wang, JJ; Xu, GX (2007). "A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy". Cancer gene therapy. 14 (2): 151–157.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Farina, HG; Pomies, M; Alonso, DF; Gomez, DE (October 2006). "Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer". Oncology Reports. 16 (4): 885–91. doi:10.3892/or.16.4.885. PMID 16969510.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Kimura, Y; Kido, T; Takaku, T; Sumiyoshi, M; Baba, K (September 2004). "Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions". Cancer Science. 95 (9): 758–64. doi:10.1111/j.1349-7006.2004.tb03258.x. PMID 15471563.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Takaku, T; Kimura, Y; Okuda, H (May 2001). "Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action". The Journal of Nutrition. 131 (5): 1409–13. doi:10.1093/jn/131.5.1409. PMID 11340091.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Liu, Zhijun.; Schwimer, Joshua.; Liu, Dong.; Greenway, Frank L.; Anthony, Catherine T.; Woltering, Eugene A. "Black Raspberry Extract and Fractions Contain Angiogenesis Inhibitors". American Chemical Society.{{cite web}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Stanley, G; Harvey, K; Slivova, V; Jiang, J; Sliva, D (April 2005). "Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells". Biochemical and Biophysical Research Communications. 330 (1): 46–52. doi:10.1016/j.bbrc.2005.02.116. PMID 15781230.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Fisher, M; Yang, LX (May 2002). "Anticancer effects and mechanisms of polysaccharide-K (PSK) : implications of cancer immunotherapy". Anticancer Research. 22 (3): 1737–54. PMID 12168863.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Oba, K; Teramukai, S; Kobayashi, M; Matsui, T; Kodera, Y; Sakamoto, J (June 2007). "Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer". Cancer Immunol Immunother. 56 (6): 905–11. doi:10.1007/s00262-006-0248-1. PMID 17106715.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Kobayashi, H; Matsunaga, K; Oguchi, Y (1995). "Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview". Cancer Epidemiology, Biomarkers & Prevention. 4 (3): 275–81. PMID 7606203.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Lee, JS; Park, BC; Ko, YJ; Choi, MK; Choi, HG; Yong, CS; Lee, JS; Kim, JA (December 2008). "Grifola frondosa (maitake mushroom) water extract inhibits vascular endothelial growth factor-induced angiogenesis through inhibition of reactive oxygen species and extracellular signal-regulated kinase phosphorylation". Journal of Medicinal Food. 11 (4): 643–51. doi:10.1089/jmf.2007.0629. PMID 19053855.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Sliva, D; Jedinak, A; Kawasaki, J; Harvey, K; Slivova, V (April 2008). "Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling". British Journal of Cancer. 98 (8): 1348–56. doi:10.1038/sj.bjc.6604319. PMC 2361714. PMID 18362935.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Lee, YS; Kang, YH; Jung, JY; Lee, S; Ohuchi, K; Shin, KH; Kang, IJ; Park, JH; Shin, HK; Lim, SS และคณะ (October 2008). "Protein glycation inhibitors from the fruiting body of Phellinus linteus". Biological & Pharmaceutical Bulletin. 31 (10): 1968–72. doi:10.1248/bpb.31.1968. PMID 18827365. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 19 December 2012.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Rodriguez, SK; Guo, W; Liu, L; Band, MA; Paulson, EK; Meydani, M (April 2006). "Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex". International Journal of Cancer. 118 (7): 1635–44. doi:10.1002/ijc.21545. PMID 16217757.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  Smith, Roderick (6 May 2009). "Antiangiogenic Substances in Blackberries, Licorice May Aid Cancer Prevention". The Angiogenesis Foundation. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 14 February 2010. สืบค้นเมื่อ 27 May 2018.{{cite web}}:  CS1 maint: uses authors parameter (ลิงก์) [แหล่งอ้างอิงทางการแพทย์ที่ไม่น่าเชื่อถือ?]
↑  Jeong, SJ; Koh, W; Lee, EO; Lee, HJ; Lee, HJ; Bae, H; Lü, J; Kim, SH (January 2011). "Antiangiogenic phytochemicals and medicinal herbs". Phytotherapy Research. 25 (1): 1–10. doi:10.1002/ptr.3224. PMID 20564543.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Izuta, H; Chikaraishi, Y; Shimazawa, M; Mishima, S; Hara, H (December 2009). "10-Hydroxy-2-decenoic acid, a major fatty acid from royal jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells". Evidence-Based Complementary and Alternative Medicine. 6 (4): 489–94. doi:10.1093/ecam/nem152. PMC 2781774. PMID 18955252.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Bruemmer, D (February 2012). "Targeting angiogenesis as treatment for obesity". Arteriosclerosis, Thrombosis, and Vascular Biology. 32 (2): 161–2. doi:10.1161/ATVBAHA.111.241992. PMID 22258895.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Heier, JS (May 2013). "Neovascular age-related macular degeneration: individualizing therapy in the era of anti-angiogenic treatments". Ophthalmology. 120 (5 Suppl): S23-5. doi:10.1016/j.ophtha.2013.01.059. PMID 23642783.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Chong, CR; Xu, J; Lu, J; Bhat, S; Sullivan, DJ; Liu, JO (April 2007). "Inhibition of angiogenesis by the antifungal drug itraconazole". ACS Chemical Biology. 2 (4): 263–70. doi:10.1021/cb600362d. PMID 17432820.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Aftab, BT; Dobromilskaya, I; Liu, JO; Rudin, CM (November 2011). "Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer". Cancer Research. 71 (21): 6764–72. doi:10.1158/0008-5472.CAN-11-0691. PMC 3206167. PMID 21896639.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  
Xu, J; Dang, Y; Ren, YR; Liu, JO (March 2010). "Cholesterol trafficking is required for mTOR activation in endothelial cells". Proceedings of the National Academy of Sciences of the United States of America. 107 (10): 4764–9. doi:10.1073/pnas.0910872107. PMC 2842052. PMID 20176935.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Ramucirumab (Cyramza) package insert
↑  "Evolving Therapeutic Paradigms for Advanced Prostate Cancer". 2011. {{cite journal}}: Cite journal ต้องการ |journal= (help)
↑  Rosenfeld, PJ; Brown, DM; Heier, JS; Boyer, DS; Kaiser, PK; Chung, CY; Kim, RY (October 2006). "Ranibizumab for neovascular age-related macular degeneration". The New England Journal of Medicine. 355 (14): 1419–31. doi:10.1056/NEJMoa054481. PMID 17021318.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  FDA News Release on Avastin, สืบค้นเมื่อ 15 April 2014
↑  Kim, JH; Scialli, AR (July 2011). "Thalidomide: the tragedy of birth defects and the effective treatment of disease". Toxicological Sciences. 122 (1): 1–6. doi:10.1093/toxsci/kfr088. PMID 21507989.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Blázquez, C; González-Feria, L; Alvarez, L; Haro, A; Casanova, ML; Guzmán, M (August 2004). "Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas". Cancer Research. 64 (16): 5617–23. doi:10.1158/0008-5472.CAN-03-3927. PMID 15313899.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  Elice, F; Rodeghiero, F (April 2012). "Side effects of anti-angiogenic drugs". Thrombosis Research. 129 Suppl 1: S50-3. doi:10.1016/S0049-3848(12)70016-6. PMID 22682133.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Maitland, ML; Kasza, KE; Karrison, T; Moshier, K; Sit, L; Black, HR; Undevia, SD; Stadler, WM; Elliott, WJ; Ratain, MJ (October 2009). "Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment". Clinical Cancer Research. 15 (19): 6250–7. doi:10.1158/1078-0432.CCR-09-0058. PMC 2756980. PMID 19773379.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)